1-20 of 53
Plasma Cell Disorders
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcomes in frail patients receiving BCMA-directed bispecific antibodies for relapsed/refractory multiple myeloma

Open Access
Benjamin Adegbite, Carlyn Rose Tan, Tala Shekarkhand, Ross S. Firestone, Eric M. Jurgens, Kevin Miller, Alexander M. Lesokhin, Gunjan L. Shah, Neha Korde, Sridevi Rajeeve, Heather J. Landau, Michael Scordo, Hani Hassoun, Kylee H. Maclachlan, Urvi A. Shah, Malin Hultcrantz, Issam S. Hamadeh, Andriy Derkach, David Nemirovsky, Sergio A. Giralt, Sham Mailankody, Saad Z. Usmani, Hamza Hashmi
Journal: Blood Advances
Blood Adv (2025) 9 (15): 4016–4022.
https://doi.org/10.1182/bloodadvances.2025015973
Published: 2025
Journal Articles

Extramedullary myeloma is genomically complex and characterized by near-universal MAPK pathway alterations

Open Access
Saurabh Zanwar, Joseph Novak, Wilson Gonsalves, Michael Howe, Esteban Braggio, S. Vincent Rajkumar, Moritz Binder, Dragan Jevremovic, Surendra Dasari, Shaji Kumar
Journal: Blood Advances
Blood Adv (2025) 9 (15): 3979–3987.
https://doi.org/10.1182/bloodadvances.2025016619
Published: 2025
Includes: Supplemental data
Journal Articles

Extramedullary plasmacytoma in children is a genetically distinct localized neoplasia curable by surgical resection

Open Access
Ilske Oschlies, Julia Richter, Amelie Alfert, Fernando Chahud, Stephanie Mueller, Ingrid Simonitsch-Klupp, Hannah von Mersi, Andishe Attarbaschi, Karoline Koch, Christoph Schaefers, Monika Brüggemann, Cecilia Bozzetti, Wilhelm Woessmann, Birgit Burkhardt, Wolfram Klapper
Journal: Blood Advances
Blood Adv (2025) 9 (15): 3909–3918.
https://doi.org/10.1182/bloodadvances.2025016596
Published: 2025
Includes: Supplemental data
Journal Articles

Fatal recurrence of IEC-HS after autologous stem cell boost in patients receiving BCMA-CAR T-cell therapy

Open Access
Snegha Ananth, Nancy Eunice Torres, Bita Sahaf, Lekha Mikkilineni, Sebastian Fernandez-Pol, Darren Salmi, Robert Negrin, Parveen Shiraz, Melody Smith, Sushma Bharadwaj, Wen-Kai Weng, Vanessa E. Kennedy, Saurabh Dahiya, Lori Muffly, David Miklos, Matthew J. Frank, Hitomi Hosoya, Surbhi Sidana
Journal: Blood Advances
Blood Adv (2025) 9 (15): 3832–3836.
https://doi.org/10.1182/bloodadvances.2025016346
Published: 2025
Includes: Supplemental data
Journal Articles

Predictive value of free light chain burden in patients with AL amyloidosis treated with bortezomib-based regimens

Open Access
Brendan Saunders, Foteini Theodorakakou, Despina Fotiou, Samuel Boullt, Benjamin Evans, Meletios A. Dimopoulos, Efstathios Kastritis, Giada Bianchi
Journal: Blood Advances
Blood Adv (2025) 9 (15): 3771–3779.
https://doi.org/10.1182/bloodadvances.2024015528
Published: 2025
Includes: Supplemental data
Journal Articles

IVIG prophylaxis should be initiated following bispecific antibody therapy in multiple myeloma regardless of IgG levels

Open Access
Rahul Banerjee, Meera Mohan, Kai Rejeski, Benjamin R. Puliafito, Diana D. Cirstea, Gurbakhash Kaur, Shonali Midha, Georgia J McCaughan, Nikhil M Kumar, Nikita Mehra, Bhausaheb Bagal, Noopur S. Raje
Journal: Blood Advances
Blood Adv bloodadvances.2025016490.
https://doi.org/10.1182/bloodadvances.2025016490
Published: 2025
Journal Articles

The Efficacy of Teclistamab in Multiple Myeloma Patients with Secondary Plasma Cell Leukemia

Open Access
Asis Shrestha, Sharmilan Thanendrarajan, Aishee Bag, Binod Dhakal, Maurizio Zangari, Samer Al Hadidi, Frits van Rhee, Anita D'Souza, Nishi Shah, Mansi R. Shah, Meera Mohan, Carolina Schinke
Journal: Blood Advances
Blood Adv bloodadvances.2025016695.
https://doi.org/10.1182/bloodadvances.2025016695
Published: 2025
Journal Articles

Can baseline Cytomegalovirus IgG titers predict Cytomegalovirus reactivation after ide-cel therapy?

Open Access
Taku Kikuchi, Ukyo Kondo, Shotaro Sugita, Miyu Watanabe, Chiaki Matsumoto, Moe Yogo, Kodai Kunisada, Haruka Sawada, Kota Sato, Tomomi Takei, Mizuki Ogura, Yu Abe, Kenshi Suzuki, Osamu Hosoya, Tadao Ishida, Nobuhiro Tsukada
Journal: Blood Advances
Blood Adv bloodadvances.2025017174.
https://doi.org/10.1182/bloodadvances.2025017174
Published: 2025
Includes: Supplemental data
Journal Articles

Intrathecal chemotherapy for ciltacabtagene autoleucel–associated movement and neurocognitive toxicity

Open Access
Kaitlin Kelly, Jennifer H. Cooperrider, Michael R. Bishop, Satyajit Kosuri, Andrzej Jakubowiak, Benjamin A. Derman
Journal: Blood Advances
Blood Adv (2025) 9 (14): 3613–3616.
https://doi.org/10.1182/bloodadvances.2024015721
Published: 2025
Includes: Supplemental data
Journal Articles

Sequential BCMA CAR-T Cell Therapy in Refractory Multiple Myeloma

Open Access
Tim Richardson, Udo Holtick, Jan Hendrik Frenking, Hishan Tharmaseelan, Hyatt Balke-Want, Ruth Flümann, Elias K Mai, Sandra Sauer, Raphael Teipel, Malte von Bonin, Michael Hallek, Christoph Scheid, Philipp Gödel
Journal: Blood Advances
Blood Adv bloodadvances.2025016712.
https://doi.org/10.1182/bloodadvances.2025016712
Published: 2025
Journal Articles

Teclistamab for patients with heavily pretreated relapsed/refractory multiple myeloma and renal impairment

Open Access
Danai Dima, Aimaz Afrough, Utkarsh Goel, Ariel F. Grajales-Cruz, Jack Khouri, Kelley Julian, Oren Pasvolsky, Rahul Banerjee, Beatrice Razzo, Christopher J. Ferreri, Mariola A. Vazquez-Martinez, James A. Davis, Aishwarya Sannareddy, Omar Castaneda, Shahzad Raza, Andrew J. Portuguese, Mahmoud R. Gaballa, Masooma S. Rana, Alex Lieberman-Cribbin, Shaun DeJarnette, Rebecca Gonzalez, Anna Chen, Megan M. Herr, Lekha Mikkilineni, Hitomi Hosoya, Evguenia Ouchveridze, Gurbakhash Kaur, Adriana Rossi, Leyla Shune, Faiz Anwer, Yi Lin, Shambavi Richard, Douglas W. Sborov, Rachid C. Baz, Alfred L. Garfall, Hans C. Lee, Larry D. Anderson, Jr., Andrew J. Cowan, Krina K. Patel, Peter M. Voorhees, Surbhi Sidana, Doris K. Hansen, Shebli Atrash, Sandra P. Susanibar-Adaniya
Journal: Blood Advances
Blood Adv (2025) 9 (14): 3408–3417.
https://doi.org/10.1182/bloodadvances.2025016059
Published: 2025
Includes: Supplemental data
Journal Articles

Longitudinal analysis of gut microbiome and metabolome correlates of response and toxicity with idecabtagene vicleucel

Open Access
Satabdi Saha, Lubna Rehman, Abdur Rehman, Faezeh Darbaniyan, Donna M. Weber, Melody Becnel, Mahmoud Gaballa, Sheeba K. Thomas, Hans C. Lee, Chia-Chi Chang, Reetakshi Arora, Meghan Menges, Salvatore Corallo, Marco L. Davila, Frederick L. Locke, Mark R. Tanner, Sattva S. Neelapu, Elizabeth J. Shpall, Christopher R. Flowers, Robert Z. Orlowski, Robert R. Jenq, Michael D. Jain, Christine Peterson, Doris K. Hansen, Neeraj Y. Saini, Krina K. Patel
Journal: Blood Advances
Blood Adv (2025) 9 (14): 3429–3440.
https://doi.org/10.1182/bloodadvances.2024014476
Published: 2025
Includes: Supplemental data
Journal Articles

Restarting teclistamab and talquetamab after prolonged dose delay may not require re–step-up dosing

Open Access
Carlyn Rose Tan, Alice Wang, David Nemirovsky, Andriy Derkach, Tala Shekarkhand, Issam Hamadeh, Kylee Maclachlan, Malin Hultcrantz, Hani Hassoun, Sham Mailankody, Alexander Lesokhin, Urvi A. Shah, Sridevi Rajeeve, Hamza Hashmi, Dhwani Patel, Ross Firestone, Eric Jurgens, Kevin Miller, Gunjan L. Shah, Michael Scordo, Heather J. Landau, Sergio A. Giralt, Neha Korde, Saad Z. Usmani
Journal: Blood Advances
Blood Adv (2025) 9 (13): 3331–3335.
https://doi.org/10.1182/bloodadvances.2024015344
Published: 2025
Journal Articles

Prognostic Impact of Focal Lesion Location and Persistence in Multiple Myeloma: Insights from Serial PET/DWI Imaging

Open Access
Carolina D Schinke, Leo Rasche, Timothy Cody Ashby, Rudy L Van Hemert, Sharmilan Thanendrarajan, Samer Al Hadidi, Maurizio Zangari, Clyde Bailey, Daisy V Alapat, MD, John D. Shaughnessy, Jr, Fenghuang Zhan, Bart Barlogie, Frits van Rhee, Niels Weinhold
Journal: Blood Advances
Blood Adv bloodadvances.2025016510.
https://doi.org/10.1182/bloodadvances.2025016510
Published: 2025
Includes: Supplemental data
Journal Articles

Blood-derived Cell-Free DNA is a Superior Biomarker for Non-Invasive DNA Methylation Profiling in Multiple Myeloma

Open Access
Robbe Heestermans, MD, Catharina Olsen, PhD, Shervine Ameli, MD, Jana Succari, MSc, Toon Janssen, PhD, Wouter De Brouwer, Dr., Ann De Becker, Isabelle Vande Broek, Dr., Marleen H Bakkus, Rik Schots, Elke De Bruyne, Ivan Van Riet
Journal: Blood Advances
Blood Adv bloodadvances.2025016480.
https://doi.org/10.1182/bloodadvances.2025016480
Published: 2025
Includes: Supplemental data
Journal Articles

Clinical outcomes in older adults treated outside clinical studies: highlighting the octogenarian experience

Open Access
Dor Shpitzer, Yael C. Cohen, Tamir Shragai, Ori Grossberger, Dana Amsterdam, Anat Reiner-Benaim, Irit Avivi
Journal: Blood Advances
Blood Adv (2025) 9 (11): 2677–2685.
https://doi.org/10.1182/bloodadvances.2025015968
Published: 2025
Includes: Supplemental data
Journal Articles

Immune-aging is linked to clinical malignancy, racial ancestry, and vaccine responses in myeloma

Open Access
Sayalee V. Potdar, Shivani Kapadia, Maryam I. Azeem, Roman Radzievski, Kiran Lakhani, Nisha S. Joseph, Jonathan L. Kaufman, Craig C. Hofmeister, Vikas A. Gupta, Sagar Lonial, Ajay K. Nooka, Kavita M. Dhodapkar, Madhav V. Dhodapkar
Journal: Blood Advances
Blood Adv (2025) 9 (10): 2438–2442.
https://doi.org/10.1182/bloodadvances.2024015680
Published: 2025
Includes: Supplemental data
Journal Articles

Universal driving restrictions beyond 4 weeks appear unnecessary following CAR-T therapy in multiple myeloma

Open Access
Rahul Banerjee, Alicia Richards, Shonali Midha, Aimaz Afrough, Faiz Anwer, Djordje Atanackovic, Shebli Atrash, Veronika Bachanova, Amer M. Beitinjaneh, Evguenia Bhurtel, Omar Castaneda Puglianini, Saurabh Chhabra, Kara I. Cicero, James A. Davis, Binod Dhakal, Danai Dima, Christopher J. Ferreri, Peter A. Forsberg, Ciara L. Freeman, Megan M. Herr, Tania Jain, Murali Janakiram, Jack Khouri, Mehmet H. Kocoglu, Anupama Kumar, Yuxin Liu, Frederick Locke, Joseph P. McGuirk, Lekha Mikkilineni, Omar Nadeem, Ricardo D. Parrondo, Oren Pasvolsky, Lauren C. Peres, Sneha Purvey, Shahzad Raza, Ran Reshef, Shambavi Richard, Adriana C. Rossi, Douglas W. Sborov, Leyla Shune, Charlotte B. Wagner, Saurabh S. Zanwar, Surbhi Sidana, Krina K. Patel, Doris K. Hansen, Shaji K. Kumar, Yi Lin, Thomas G. Martin, Peter M. Voorhees, Larry D. Anderson, Jr, Andrew J. Cowan, Gurbakhash Kaur
Journal: Blood Advances
Blood Adv (2025) 9 (9): 2336–2340.
https://doi.org/10.1182/bloodadvances.2025016131
Published: 2025
Includes: Supplemental data
Journal Articles

Diffuse lung involvement as a rare presentation of systemic AL amyloidosis: a retrospective cohort study

Open Access
Amy Song, George Mellgard, Claudia Bellofiore, Marco Basset, Mario Nuvolone, Andrea Foli, Giampaolo Merlini, Mathew S. Maurer, Markus Y. Mapara, Divaya Bhutani, Suzanne Lentzsch, Hiram Shaish, Giovanni Palladini, Rajshekhar Chakraborty, Paolo Milani
Journal: Blood Advances
Blood Adv (2025) 9 (9): 2221–2225.
https://doi.org/10.1182/bloodadvances.2024015646
Published: 2025
Includes: Supplemental data
Journal Articles

Prior exposure to belantamab mafodotin influences outcomes with idecabtagene vicleucel in patients with multiple myeloma

Open Access
Bhavesh Mohan Lal, Marah Alzubi, Jawad Alrawabdeh, John D. Shaughnessy, Jr., Fenghuang Zhan, Eric R. Siegel, Carolina Schinke, Sharmilan Thanendrarajan, Maurizio Zangari, Frits van Rhee, Samer Al Hadidi
Journal: Blood Advances
Blood Adv (2025) 9 (9): 2155–2158.
https://doi.org/10.1182/bloodadvances.2024015648
Published: 2025